Morgan Stanley Issues Pessimistic Forecast for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) had its price objective decreased by Morgan Stanley from $30.00 to $23.00 in a report issued on Tuesday morning,Benzinga reports. Morgan Stanley currently has an overweight rating on the medical instruments supplier's stock.

XRAY has been the topic of a number of other research reports. Mizuho initiated coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 target price on the stock. UBS Group decreased their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a report on Tuesday, December 3rd. Leerink Partners lowered shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Leerink Partnrs lowered DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th. Finally, Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research note on Friday, October 25th. Eight research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $27.91.

DENTSPLY SIRONA Stock Down 2.0 %

NASDAQ XRAY traded down $0.40 on Tuesday, hitting $19.19. 3,304,276 shares of the stock were exchanged, compared to its average volume of 3,100,195. The company has a market cap of $3.81 billion, a PE ratio of -9.28, a PEG ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $37.60. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a 50-day moving average price of $21.18 and a 200-day moving average price of $24.11.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company's revenue was up .4% on a year-over-year basis. During the same period last year, the business posted $0.49 EPS. Sell-side analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.34%. The ex-dividend date of this dividend is Friday, December 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -30.92%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Hedge funds have recently bought and sold shares of the company. UMB Bank n.a. grew its holdings in shares of DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA in the third quarter valued at approximately $27,000. LRI Investments LLC grew its stake in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock worth $31,000 after buying an additional 564 shares in the last quarter. Kennebec Savings Bank acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $35,000. Finally, Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at $32,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.